Europe Bioinformatics Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
 Período de previsão |
2023 –2029 |
 Tamanho do mercado (ano base ) | |
 Tamanho do mercado ( Ano de previsão) | USD 1,459.71 Million |
 CAGR |
% |
| Principais participantes do mercado |
|
>Mercado Europeu de Bioinformática, por tipo (ferramentas de gestão do conhecimento, software e serviços de bioinformática), setor (biotecnologia médica, académicos, biotecnologia animal, biotecnologia agrícola, biotecnologia ambiental, biotecnologia forense e outros), aplicação (genómica e desenvolvimento de medicamentos , proteómica, estudos evolutivos , Estudos Agrícolas, Ciências Veterinárias, Metabolómica , Transcriptómica e Outras), Modo de Compra (Compra em Grupo e Compra Individual), Método (Genómica e Proteómica) Utilizador Final, (Institutos Académicos e de Investigação, Organização de Investigação Clínica, Empresas Biotecnológicas e Farmacêuticas, Laboratórios de Investigação, Hospital e Outros) - Tendências e Previsões do Setor para 2029.
Análise e insights do mercado da bioinformática na Europa
Os impulsionadores responsáveis pelo crescimento do mercado da bioinformática são o menor custo do sequenciamento genético por base, a crescente necessidade de bioinformática, amplo portfólio de produtos oferecido pelos principais players do mercado e o uso da bioinformática na medicina personalizada e o aumento do financiamento do setor público-privado para a bioinformática. No entanto, os fatores que deverão conter o crescimento do mercado são o aumento do custo da instrumentação, a dificuldade na análise de bioinformática clínica e a cibersegurança em bioinformática.
Por outro lado, as iniciativas estratégicas dos players do mercado, o desenvolvimento de produtos, os avanços na tecnologia bioinformática e o aumento dos gastos em saúde podem funcionar como uma oportunidade para o crescimento do mercado bioinformática. No entanto, a necessidade de conhecimentos especializados, os desafios na implementação da tecnologia bioinformática nos laboratórios clínicos e a aprovação regulamentar podem criar desafios para o mercado bioinformático. Existem desenvolvimentos recentes relacionados com o mercado mundial de bioinformática.
Espera-se que o aumento das atividades de investigação e desenvolvimento em bioinformática na Europa impulsione o crescimento do mercado. A Data Bridge Market Research analisa que o mercado europeu de bioinformática crescerá a um CAGR de 19,5% durante o período de previsão de 2022 a 2029.
|
Métrica de reporte |
Detalhes |
|
Período de previsão |
2022 a 2029 |
|
Ano base |
2021 |
|
Anos históricos |
2020 (personalizável para 2019 - 2014) |
|
Unidades Quantitativas |
Receita em milhões de dólares, preços em dólares |
|
Segmentos cobertos |
Por Tipo (Ferramentas de Gestão do Conhecimento, Software e Serviços de Bioinformática), Setor (Biotecnologia Médica, Académico, Biotecnologia Animal, Biotecnologia Agrícola, Biotecnologia Ambiental, Biotecnologia Forense e Outros), Aplicação (Genómica e Desenvolvimento de Medicamentos, Proteómica, Estudos Evolutivos , Estudos Agrícolas, Ciência Veterinária, Metabolómica, Transcriptómica e Outros), Modo de Compra (Compra em Grupo e Compra Individual), Método (Genómica e Proteómica) Utilizador Final, (Institutos Académicos e de Investigação, Organização de Investigação Clínica, Empresas Biotecnológicas e Farmacêuticas, Laboratórios de Investigação, Hospitalar e Outros) |
|
Países abrangidos |
Germany, France, U.K., Italy, Russia, Spain, Switzerland, Netherlands, Belgium, Turkey, Rest of Europe |
|
Market Players Covered |
Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Waters Corporation, Dassault Systèmes, Bayer AG, PerkinElmer Inc., Seven Bridges Genomics, Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam and GenoFAB, Inc. |
Market Definition
Bioinformatics combines computer programming, big data, and Molecular Biology, which enables scientists to understand and identify patterns in biological data. It is particularly useful in studying genomes and DNA sequencing, as it allows scientists to organize large amounts of data.
From genetics to toxicology to mycology and radiobiology, there are scores of branches of Biology to specialize in. And out of the many, Bioinformatics is one of the intriguing fields which enables you to identify, evaluate, store, and retrieve biological information. Being an interdisciplinary field of study, it incorporates various applications of Computer Science, Statistics, and Biology to develop software applications for understanding biological data like DNA sequencing, protein analysis, evolutionary genetics, etc.
- In the coming future, important decisions related to bioinformatics on drug discovery will be made by individuals who not only understand the biology but can also use the bioinformatics tools and the knowledge they release to develop hypotheses and identify quality targets
Europe Bioinformatics Market Dynamics
Drivers
- Wide Product Portfolio Offered by Major Players
The advancement and growing research in the field of bioinformatics offered by major players allows them to develop and launch new products in the market. The different sequencing instruments are in the bioinformatics market.
For instance,
- The product portfolio of QIAGEN consists of bioinformatics products and services such as custom automated workflows, curation services, and scalable bioinformatics services
- BGI consists of sequencing services and mass spectrometry services such as proteomics, metabolomics, multi-omics, and biologics characterization
- The gene synthesis and molecular biology by Eurofins Scientific provides gene synthesis and Molecular Biology products
Hence, the product portfolio for the companies working in this market is vast, due to which the companies' revenue has increased continuously from the past recent revenue year. This is expected to propel the market size and is expected to act as a driver for the bioinformatics market in the forecast period
- Growing Need for Bioinformatics
As genomics-focused pharmacology continues to play a greater role in the treatment of various chronic diseases, especially cancer, next-generation sequencing (NGS) is evolving as a powerful tool for providing a deeper and more precise insight into the molecular underpinnings of individual tumors and specific receptors. Informatics is essential in biological research involving biologists who learn programming, computer programmers, mathematicians, or database managers who learn the foundations of biology
For instance,
- NGS has also been explored for comprehensive profiling of pharmacogenetics with relevance to drug Pharmacokinetics and Pharmacodynamics. An initial report in 2017 suggested that this technology may represent a reliable and efficient tool for discovering both common and rare genetic variations in these genes
- Bioinformatics is the application of tools of computation and analysis to the capture and interpretation of biological data
Bioinformatics has the power to transform oncology's outlook and push forward the vision of precision medicine by adopting genome-focused pharmacology to treat chronic diseases. Thus, the increase in the adoption of genome-focused pharmacology for chronic disease treatment acts as a driver for the bioinformatics market.
Opportunities
- Use Of Bioinformatics In Personalized Medicine
The growth curve for bioinformatics market clinical applications is following an upward trend as established applications are gaining momentum and new ones are finding a foothold. Product development in the past years has helped the market size to grow. This also shows the support of the regulatory agency for allowing these products in the market.
- Strategic Initiatives by Market Players
Bioinformatics delivers purposeful biological information, as it is a part of life science dealing with the comprehension and planning of genomes. A genome is the complex arrangement of genetic sets present in a cell or a whole living being. Personalized medicine is a combinatorial way to deal with individual-specific health care. The patient-specific medication development advanced through bioinformatics tools.
For instance-
- In December 2020, Quest Diagnostics Incorporated invested in Structural Bioinformatics, A Leader in Computational Proteomics and Structural Pharmacogenomics. The investment resulted in the joint development of a series of database modules of the novel, structurally variant proteins and market these products directly to the pharmaceutical and biotechnology industry for use in the development of personalized medicine
- In 2019, BGI announced that Flow Pharma had selected BGI (A subsidiary of BGI Group) for developing the use of NSG in Drug Development
Hence the growing prevalence of chronic disease and increased drug-resistance issues in traditional medication have generated the demand for increasing bioinformatics in drug development. This is expected to be one of the major factors expected to drive the market growth in the forecast period.
Restraints/Challenges
- Difficulty In Clinical Bioinformatics Analysis
The largely untapped potential of big data analytics is a feed buzz that has been exacerbated by the production of many next-generation data sets that seek to answer long-standing questions about the biology of human diseases. Although these approaches are likely to be a powerful means of unveiling new biological insights, several significant challenges currently hinder efforts to harness the power of big data. Typical challenges include the effective assessment of analytical software tools, the speeding up of the overall process using hybrid parallel computing (HPC) parallelization and acceleration technology, the advancement of automation strategies, data storage alternatives, and, finally, the development of new methods for the full utilization of results across multiple experimental conditions.
Considering the uncertainty about the importance of certain bioinformatics tests, they cannot be used as a replacement for careful clinical evaluation. This may greatly enhance the analysis of gene variants by facilitating data sharing and straightforward exchange of selected variants associated with the phenotype. Thus, the difficulty in clinical bioinformatics is expected to restrain the market growth.
- Cyber Security Concerns in Bioinformatics
Era software is known to contain vulnerabilities caused by imperfect code and misconfiguration. NGS-related software used to operate sequencing and laboratory equipment or carry out bioinformatics analyzes is no exception. Software vulnerabilities are exploited to gain unauthorized access to computer systems or networks, leak data, crash or otherwise disrupt various services.
However, the increasing computerization of DNA technology and biotechnology raises new bio-cyber security concerns. Vulnerabilities typically associated with traditional computer systems -- like the processing of untrusted input, side-channel leaks, poor authentication, falsified data, and vulnerabilities in cyber-physical systems -- now exist in biotechnology. The emerging bio-cyber security threats have threatened the DNA-Information Systems in bioinformatics.
For instance;
- In 2020, The REvil or Sodinokibi ransomware group will take the credit for hacking and stealing 1 Terabyte (TB) of data from 10x Genomics which is for COVID-19 research
- In 2018, Genomics England shifted genetic blueprint data for its 100,000 Genomes Project after being targeted by cyber-attacks from foreign parties. This allows the breach of data and can lead to misuse of individual genome
COVID-19 Impact on the Europe Bioinformatics Market
During the pandemic, the Europe bioinformatics sector is one that focuses on using a combination of biology and information technology. At the heart of the industry is biological data, which is analyzed and transformed using IT techniques. Bioinformatics has always had huge potential when it comes to providing essential support to many areas of scientific research. The tools that Bioinformatics can provide allow scientists to get to grips with larger data sets and to mine and analyze them to discover crucial information that could lead to key discoveries. Genetics and genomes have been the primary focus of Bioinformatics in recent years, including comparative genomics, DNA microarrays, and functional genomics.
Recent Development
- In March 2022, Thermo Fisher Scientific Inc launched the CE-IVD Marked Next-Generation Sequencing (NGS) Instrument for Use in Clinical Labs. The CE-IVD Marked Next-Generation Sequencing Instrument is used to perform diagnostic testing and clinical research on a single instrument. The launch of the instrument resulted in the addition of a new product in the product range and the distribution of the NGS instrument, which is expected to increase the product revenue.
Europe Bioinformatics Market Scope
Europe bioinformatics market is segmented on the basis of six segments: type, sector, application, purchase mode, genomics, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Knowledge Management Tools
- Bioinformatics Software
- Services
On the basis of type, the Europe bioinformatics market is segmented into knowledge management tools, bioinformatics software, and services.
Sector
- Medical biotechnology
- Academics
- Animal Biotechnology
- Agricultural biotechnology
- Environmental Biotechnology
- Forensic biotechnology
- Others
On the basis of sector, the Europe bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others.
Application
- Genomics and Drug Development
- Proteomics
- Evolutionary Studies
- Agricultural Studies
- Veterinary Science
- Metabolomics
- Transcriptomics
- Others
On the basis of application, the Europe bioinformatics market is segmented into genomics and drug development, proteomics, evolutionary studies, agricultural studies, veterinary science, metabolomics, transcriptomics, and others.
Purchase Mode
- Group Purchase
- Individual Purchase
On the basis of purchase mode, the Europe bioinformatics market is segmented into group purchases and individual purchases.
Method
- Genomics
- Proteomics
On the basis of method, the Europe bioinformatics market is segmented into genomics and proteomics.
End User
- Research and Academic Institutes
- Clinical Research Organization
- Biotech and Pharmaceutical Companies
- Research Laboratories
- Hospital
- Outros
Com base no utilizador final, o mercado europeu de bioinformática está segmentado em institutos académicos e de investigação, organizações de investigação clínica, empresas biotecnológicas e farmacêuticas, laboratórios de investigação, hospitais, entre outros.
Análise/perspetivas regionais do mercado europeu de bioinformática
O mercado europeu de bioinformática é analisado, e são fornecidos insights e tendências de tamanho de mercado por regiões, tipo, setor, aplicação, modo de compra, genómica e utilizador final. conforme acima referenciado.
Os países abrangidos no relatório do mercado europeu de Bioinformática são Alemanha, França, Reino Unido, Itália, Rússia, Espanha, Suíça, Holanda, Bélgica, Turquia, Resto da Europa.
Espera-se que a Alemanha domine o mercado devido ao aumento da consciencialização sobre a sequenciação de bioinformática e ao aumento da contagem de colaborações entre empresas e institutos de investigação em bioinformática na Alemanha deverão impulsionar o crescimento do mercado.
A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações nas regulamentações do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como novas vendas, vendas de reposição, demografia do país, epidemiologia de doenças e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e a disponibilidade das marcas e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais que impactam os canais de vendas, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.
Cenário competitivo e análise da quota de mercado da bioinformática na Europa
O panorama competitivo do mercado europeu de bioinformática fornece detalhes do concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença na Europa, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produtos, largura e amplitude do produto. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado europeu de bioinformática.
Alguns dos principais players que operam no mercado europeu de bioinformática são a Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN, SOPHiA GENETICS., BGI, Eurofins Scientific, Waters Corporation, Dassault Systèmes, Bayer AG, PerkinElmer Inc., Seven Bridges Genomics, Quest Diagnostics Incorporated., AstridBio Technologies Inc., BioBam e GenoFAB, Inc.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE BIOINFORMATICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 TYPE SEGMENT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 THE CATEGORY VS TIME GRID
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 REGULATIONS OF THE EUROPE BIOINFORMATICS MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 DECREASE IN THE COST OF GENETIC SEQUENCING PER BASE
6.1.2 GROWING NEED FOR BIOINFORMATICS
6.1.3 WIDE PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYERS
6.1.4 USE OF BIOINFORMATICS IN PERSONALIZED MEDICINE
6.1.5 INCREASING PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS
6.2 RESTRAINTS
6.2.1 HIGH COST OF INSTRUMENTATION
6.2.2 DIFFICULTY IN CLINICAL BIOINFORMATICS ANALYSIS
6.2.3 CYBER SECURITY CONCERNS IN BIOINFORMATICS
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER
6.3.2 PRODUCT DEVELOPMENT IN RECENT YEARS
6.3.3 ADVANCEMENT IN BIOINFORMATICS TECHNOLOGY
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS TO PERFORM BIOINFORMATICS TECHNOLOGY
6.4.2 CHALLENGES TO IMPLEMENTING BIOINFORMATICS TECHNOLOGY IN THE CLINICAL LABS
7 EUROPE BIOINFORMATICS MARKET, BY TYPE
7.1 OVERVIEW
7.2 SERVICES
7.2.1 DIAGNOSTICS CONSULTATION
7.2.2 DATA ANALYSIS
7.2.2.1 STRUCTURAL
7.2.2.2 FUNCTIONAL
7.3 BIOINFORMATICS SOFTWARE
7.3.1 INFORMATICS INFRASTRUCTURE AND PIPELINE SETUP
7.3.2 SAMPLE AND EXPERIMENT MANAGEMENT
7.3.3 SEQUENCING DATA ANALYSIS
7.3.3.1 SEQUENCE ANALYSIS PLATFORM
7.3.3.2 SEQUENCE ALIGNMENT PLATFORM
7.3.3.3 SEQUENCE MANIPULATION PLATFORM
7.3.3.4 STRUCTURAL ANALYSIS PLATFORM
7.3.3.5 OTHERS
7.3.4 BIOLOGICAL DATA INTERPRETATION
7.3.5 SPECIALIZED BIOINFORMATICS APPLICATIONS
7.3.5.1 SINGLE CELL GENE EXPRESSION
7.3.5.2 GENE EXPRESSION
7.3.5.3 VARIANT DETECTION
7.3.5.4 CNV ANALYSIS
7.3.5.5 METAGENOMICS
7.3.5.6 METHYLATION
7.3.5.7 CHIP-SEQ
7.3.5.8 NON-CODING RNA EXPRESSION
7.3.5.9 OTHERS
7.3.6 OTHERS
7.4 KNOWLEDGE MANAGEMENT TOOLS
7.4.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS
7.4.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS
8 EUROPE BIOINFORMATICS MARKET, BY SECTOR
8.1 OVERVIEW
8.2 MEDICAL BIOTECHNOLOGY
8.3 ACADEMICS
8.4 ANIMAL BIOTECHNOLOGY
8.5 AGRICULTURAL BIOTECHNOLOGY
8.6 ENVIRONMENTAL BIOTECHNOLOGY
8.7 FORENSIC BIOTECHNOLOGY
8.8 OTHERS
9 EUROPE BIOINFORMATICS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 GENOMICS & DRUG DEVELOPMENT
9.2.1 SERVICES
9.2.2 SEQUENCING PLATFORMS
9.2.3 KNOWLEDGE MANAGEMENT TOOLS
9.2.4 GENOMICS & DRUG DEVELOPMENT BY TYPE
9.2.4.1 PREVENTIVE MEDICINE
9.2.4.2 MOLECULAR MEDICINE
9.2.4.3 PERSONALIZED MEDICINE
9.2.4.4 CHEMOINFORMATICS AND DRUG DESIGN
9.2.4.5 ANTIBIOTIC RESISTANCE
9.3 PROTEOMICS
9.3.1 SERVICES
9.3.2 SERVICES SEQUENCING PLATFORMS
9.3.3 KNOWLEDGE MANAGEMENT TOOLS
9.4 AGRICULTURAL STUDIES
9.4.1 SERVICES
9.4.2 SERVICES SEQUENCING PLATFORMS
9.4.3 KNOWLEDGE MANAGEMENT TOOLS
9.5 TRANSCRIPTOMICS
9.5.1 SERVICES
9.5.2 SERVICES SEQUENCING PLATFORMS
9.5.3 KNOWLEDGE MANAGEMENT TOOLS
9.6 METABOLOMICS
9.6.1 SERVICES
9.6.2 SERVICES SEQUENCING PLATFORMS
9.6.3 KNOWLEDGE MANAGEMENT TOOLS
9.7 EVOLUTIONARY STUDIES
9.7.1 SERVICES
9.7.2 SERVICES SEQUENCING PLATFORMS
9.7.3 KNOWLEDGE MANAGEMENT TOOLS
9.8 VETERINARY SCIENCE
9.8.1 SERVICES
9.8.2 SERVICES SEQUENCING PLATFORMS
9.8.3 KNOWLEDGE MANAGEMENT TOOLS
9.9 OTHERS
9.9.1 SERVICES
9.9.2 SERVICES SEQUENCING PLATFORMS
9.9.3 KNOWLEDGE MANAGEMENT TOOLS
10 EUROPE BIOINFORMATICS MARKET, BY PURCHASE MODE
10.1 OVERVIEW
10.2 GROUP PURCHASE
10.3 INDIVIDUAL PURCHASE
11 EUROPE BIOINFORMATICS MARKET, BY METHOD
11.1 OVERVIEW
11.2 GENOMICS
11.2.1 DNA
11.2.2 RNA
11.3 PROTEOMICS
12 EUROPE BIOINFORMATICS MARKET, BY END USER
12.1 OVERVIEW
12.2 RESEARCH AND ACADEMIC INSTITUTES
12.3 CLINICAL RESEARCH ORGANIZATION
12.4 BIOTECH AND PHARMACEUTICAL COMPANIES
12.5 RESEARCH LABORATORIES
12.6 HOSPITALS
12.7 OTHERS
13 EUROPE BIOINFORMATICS MARKET, BY REGION
13.1 EUROPE
13.1.1 GERMANY
13.1.2 FRANCE
13.1.3 U.K.
13.1.4 ITALY
13.1.5 RUSSIA
13.1.6 SPAIN
13.1.7 SWITZERLAND
13.1.8 NETHERLANDS
13.1.9 BELGIUM
13.1.10 TURKEY
13.1.11 REST OF EUROPE
14 EUROPE BIOINFORMATICS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 BAYER AG
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 THERMO FISHER SCIENTIFIC INC
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 EUROFINS SCIENTIFIC
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 DASSAULT SYSTÈMES
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 AGILENT TECHNOLOGIES, INC
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 ASTRIDBIO TECHNOLOGIES INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 BGI (A SUBSIDIARY OF BGI GROUP)
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 BIOBAM
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 DNANEXUS INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 DNASTAR
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 GENOFAB, INC
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 ILLUMINA, INC
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.4 RECENT DEVELOPMENTS
16.13 PARTEK INCORPORATED
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 PERKINELMER INC.
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENTS
16.15 QIAGEN
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 QUEST DIAGNOSTICS INCORPORATED (2021)
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.17 SEVEN BRIDGES GENOMICS
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 SOPHIA GENETICS
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENTS
16.19 STRAND LIFE SCIENCES
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 WATERS CORPORATION
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
Lista de Tabela
TABLE 1 BIOINFORMATICSCOST PER SAMPLE
TABLE 2 EUROPE BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 3 EUROPE SERVICES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 EUROPE SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 5 EUROPE DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 6 EUROPE BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 EUROPE BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 8 EUROPE SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 9 EUROPE SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 10 EUROPE KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 EUROPE KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 12 EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 13 EUROPE MEDICAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 EUROPE ACADEMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 EUROPE ANIMAL TECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 EUROPE AGRICULTURAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 EUROPE ENVIRONMENTAL BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 EUROPE FORENSIC BIOTECHNOLOGY IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 21 EUROPE GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 EUROPE GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 23 EUROPE GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 24 EUROPE PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 EUROPE PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 EUROPE AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 EUROPE AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 28 EUROPE TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 EUROPE TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 30 EUROPE METABOLOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 EUROPE METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 32 EUROPE EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 EUROPE EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 34 EUROPE VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 EUROPE VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 36 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 38 EUROPE BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 39 EUROPE GROUP PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 EUROPE INDIVIDUAL PURCHASE IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 EUROPE BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 42 EUROPE GENOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 EUROPE GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 44 EUROPE PROTEOMICS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 45 EUROPE BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 46 EUROPE RESEARCH AND ACADEMIC INSTITUTES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 47 EUROPE CLINICAL RESEARCH ORGANIZATION IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 48 EUROPE BIOTECH AND PHARMACEUTICAL COMPANIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 EUROPE RESEARCH LABORATORIES IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 50 EUROPE HOSPITALS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 52 EUROPE BIOINFORMATICS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 53 EUROPE BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 54 EUROPE SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 55 EUROPE DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 56 EUROPE BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 57 EUROPE SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 58 EUROPE SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 59 EUROPE KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 60 EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 61 EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 62 EUROPE GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 63 EUROPE GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 64 EUROPE PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 65 EUROPE AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 66 EUROPE TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 67 EUROPE METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 68 EUROPE EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 69 EUROPE VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 70 EUROPE OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 71 EUROPE BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 72 EUROPE BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 73 EUROPE GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 74 EUROPE BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 75 GERMANY BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 76 GERMANY SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 77 GERMANY DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 78 GERMANY BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 79 GERMANY SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 80 GERMANY SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 81 GERMANY KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 82 GERMANY BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 83 GERMANY BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 84 GERMANY GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 85 GERMANY GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 86 GERMANY PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 87 GERMANY AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 88 GERMANY TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 89 GERMANY METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 90 GERMANY EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 91 GERMANY VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 92 GERMANY OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 93 GERMANY BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 94 GERMANY BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 95 GERMANY GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 96 GERMANY BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 97 FRANCE BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 98 FRANCE SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 99 FRANCE DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 100 FRANCE BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 101 FRANCE SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 102 FRANCE SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 103 FRANCE KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 104 FRANCE BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 105 FRANCE BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 106 FRANCE GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 107 FRANCE GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 108 FRANCE PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 109 FRANCE AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 110 FRANCE TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 111 FRANCE METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 112 FRANCE EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 113 FRANCE VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 114 FRANCE OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 115 FRANCE BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 116 FRANCE BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 117 FRANCE GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 118 FRANCE BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 119 U.K. BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 120 U.K. SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 121 U.K. DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 122 U.K. BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 123 U.K. SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 124 U.K. SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 125 U.K. KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 126 U.K. BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 127 U.K. BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 128 U.K. GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 129 U.K. GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 130 U.K. PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 131 U.K. AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 132 U.K. TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 133 U.K. METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 134 U.K. EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 135 U.K. VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 136 U.K. OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 137 U.K. BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 138 U.K. BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 139 U.K GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 140 U.K. BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 141 ITALY BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 142 ITALY SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 143 ITALY DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 144 ITALY BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 145 ITALY SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 146 ITALY SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 147 ITALY KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 148 ITALY BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 149 ITALY BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 150 ITALY GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 151 ITALY GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 152 ITALY PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 153 ITALY AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 154 ITALY TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 155 ITALY METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 156 ITALY EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 157 ITALY VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 158 ITALY OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 159 ITALY BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 160 ITALY BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 161 ITALY GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 162 ITALY BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 163 RUSSIA BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 164 RUSSIA SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 165 RUSSIA DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 166 RUSSIA BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 167 RUSSIA SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 168 RUSSIA SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 169 RUSSIA KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 170 RUSSIA BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 171 RUSSIA BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 172 RUSSIA GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 173 RUSSIA GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 174 RUSSIA PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 175 RUSSIA AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 176 RUSSIA TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 177 RUSSIA METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 178 RUSSIA EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 179 RUSSIA VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 180 RUSSIA OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 181 RUSSIA BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 182 RUSSIA BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 183 RUSSIA GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 184 RUSSIA BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 185 SPAIN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 186 SPAIN SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 187 SPAIN DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 188 SPAIN BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 189 SPAIN SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 190 SPAIN SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 191 SPAIN KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 192 SPAIN BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 193 SPAIN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 194 SPAIN GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 195 SPAIN GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 196 SPAIN PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 197 SPAIN AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 198 SPAIN TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 199 SPAIN METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 200 SPAIN EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 201 SPAIN VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 202 SPAIN OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 203 SPAIN BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 204 SPAIN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 205 SPAIN GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 206 SPAIN BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 207 SWITZERLAND BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 208 SWITZERLAND SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 209 SWITZERLAND DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 210 SWITZERLAND BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 211 SWITZERLAND SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 212 SWITZERLAND SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 213 SWITZERLAND KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 214 SWITZERLAND BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 215 SWITZERLAND BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 216 SWITZERLAND GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 217 SWITZERLAND GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 218 SWITZERLAND PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 219 SWITZERLAND AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 220 SWITZERLAND TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 221 SWITZERLAND METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 222 SWITZERLAND EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 223 SWITZERLAND VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 224 SWITZERLAND OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 225 SWITZERLAND BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 226 SWITZERLAND BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 227 SWITZERLAND GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 228 SWITZERLAND BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 229 NETHERLANDS BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 230 NETHERLANDS SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 231 NETHERLANDS DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 232 NETHERLANDS BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 233 NETHERLANDS SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 234 NETHERLANDS SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 235 NETHERLANDS KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 236 NETHERLANDS BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 237 NETHERLANDS BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 238 NETHERLANDS GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 239 NETHERLANDS GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 240 NETHERLANDS PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 241 NETHERLANDS AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 242 NETHERLANDS TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 243 NETHERLANDS METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 244 NETHERLANDS EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 245 NETHERLANDS VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 246 NETHERLANDS OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 247 NETHERLANDS BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 248 NETHERLANDS BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 249 NETHERLANDS GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 250 NETHERLANDS BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 251 BELGIUM BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 252 BELGIUM SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 253 BELGIUM DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 254 BELGIUM BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 255 BELGIUM SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 256 BELGIUM SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 257 BELGIUM KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 258 BELGIUM BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 259 BELGIUM BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 260 BELGIUM GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 261 BELGIUM GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 262 BELGIUM PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 263 BELGIUM AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 264 BELGIUM TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 265 BELGIUM METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 266 BELGIUM EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 267 BELGIUM VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 268 BELGIUM OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 269 BELGIUM BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 270 BELGIUM BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 271 BELGIUM GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 272 BELGIUM BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 273 TURKEY BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 274 TURKEY SERVICES IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 275 TURKEY DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 276 TURKEY BIOINFORMATICS SOFTWARE IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 277 TURKEY SEQUENCING DATA ANALYSIS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 278 TURKEY SPECIALIZED BIOINFORMATICS APPLICATIONS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 279 TURKEY KNOWLEDGE MANAGEMENT TOOLS IN BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 280 TURKEY BIOINFORMATICS MARKET, BY SECTOR, 2020-2029 (USD MILLION)
TABLE 281 TURKEY BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 282 TURKEY GENOMICS & DRUG DEVELOPMENT IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 283 TURKEY GENOMICS & DRUG DEVELOPMENT BY TYPE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 284 TURKEY PROTEOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 285 TURKEY AGRICULTURAL STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 286 TURKEY TRANSCRIPTOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 287 TURKEY METABOLOMICS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 288 TURKEY EVOLUTIONARY STUDIES IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 289 TURKEY VETERINARY SCIENCE IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 290 TURKEY OTHERS IN BIOINFORMATICS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 291 TURKEY BIOINFORMATICS MARKET, BY PURCHASE MODE, 2020-2029 (USD MILLION)
TABLE 292 TURKEY BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 293 TURKEY GENOMICS IN BIOINFORMATICS MARKET, BY METHOD, 2020-2029 (USD MILLION)
TABLE 294 TURKEY BIOINFORMATICS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 295 REST OF EUROPE BIOINFORMATICS MARKET, BY TYPE, 2020-2029 (USD MILLION)
Lista de Figura
FIGURE 1 EUROPE BIOINFORMATICS MARKET: SEGMENTATION
FIGURE 2 EUROPE BIOINFORMATICS MARKET: GEOGRAPHIC SCOPE
FIGURE 3 EUROPE BIOINFORMATICS MARKET: DATA TRIANGULATION
FIGURE 4 EUROPE BIOINFORMATICS MARKET: SNAPSHOT
FIGURE 5 EUROPE BIOINFORMATICS MARKET: BOTTOM-UP APPROACH
FIGURE 6 EUROPE BIOINFORMATICS MARKET: TOP-DOWN APPROACH
FIGURE 7 EUROPE BIOINFORMATICS MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 EUROPE BIOINFORMATICS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE BIOINFORMATICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE BIOINFORMATICS MARKET: APPLICATION COVERAGE GRID
FIGURE 11 EUROPE BIOINFORMATICS MARKET: THE CATEGORY VS TIME GRID
FIGURE 12 EUROPE BIOINFORMATICS MARKET SEGMENTATION
FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE EUROPE DENTAL LABMARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 GROWING APPLICATIONS OF BIOINFORMATICS AND LOW COST OF BIOINFORMATICS SEQUENCING ARE EXPECTED TO DRIVE THE MARKET FOR EUROPE BIOINFORMATICS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 15 SERVICES SEGMENT ARE EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE BIOINFORMATICS MARKET IN 2019 & 2026
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE BIOINFORMATICS MARKET
FIGURE 17 DECREASE IN COST OF PER BASE SEQUENCING
FIGURE 18 GROWING NEED FOR BIOINFORMATICS IN VITAL APPLICATIONS
FIGURE 19 EUROPE BIOINFORMATICS MARKET: BY TYPE, 2021
FIGURE 20 EUROPE BIOINFORMATICS MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 21 EUROPE BIOINFORMATICS MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 22 EUROPE BIOINFORMATICS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 23 EUROPE BIOINFORMATICS MARKET: BY SECTOR, 2021
FIGURE 24 EUROPE BIOINFORMATICS MARKET: BY SECTOR, 2022-2029 (USD MILLION)
FIGURE 25 EUROPE BIOINFORMATICS MARKET: BY SECTOR, CAGR (2022-2029)
FIGURE 26 EUROPE BIOINFORMATICS MARKET: BY SECTOR, LIFELINE CURVE
FIGURE 27 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, 2021
FIGURE 28 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 29 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 30 EUROPE BIOINFORMATICS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 31 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, 2021
FIGURE 32 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, 2022-2029 (USD MILLION)
FIGURE 33 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, CAGR (2022-2029)
FIGURE 34 EUROPE BIOINFORMATICS MARKET: BY PURCHASE MODE, LIFELINE CURVE
FIGURE 35 EUROPE BIOINFORMATICS MARKET: BY METHOD, 2021
FIGURE 36 EUROPE BIOINFORMATICS MARKET: BY METHOD, 2022-2029 (USD MILLION)
FIGURE 37 EUROPE BIOINFORMATICS MARKET: BY METHOD, CAGR (2022-2029)
FIGURE 38 EUROPE BIOINFORMATICS MARKET: BY METHOD, LIFELINE CURVE
FIGURE 39 EUROPE BIOINFORMATICS MARKET: BY END USER, 2021
FIGURE 40 EUROPE BIOINFORMATICS MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 41 EUROPE BIOINFORMATICS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 42 EUROPE BIOINFORMATICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 43 EUROPE BIOINFORMATICS MARKET: SNAPSHOT (2021)
FIGURE 44 EUROPE BIOINFORMATICS MARKET: BY COUNTRY (2021)
FIGURE 45 EUROPE BIOINFORMATICS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 46 EUROPE BIOINFORMATICS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 47 EUROPE BIOINFORMATICS MARKET: BY TYPE (2022-2029)
FIGURE 48 EUROPE BIOINFORMATICS MARKET: COMPANY SHARE 2021 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
